Autolus Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-208.38	-148.84	-142.1	-142.09	-123.85	-44.75	-19.73	-12.55
Depreciation & Amortization	10.62	10.85	12.19	5.66	4.61	1.71	1.01	0.48
Share-Based Compensation	11.2	12.01	9.94	20.11	30.21	6.77	3.15	2.26
Other Operating Activities	40.97	13.66	2.11	-1.43	-12.46	4.74	-0.8	-0.03
Operating Cash Flow	-145.59	-112.31	-117.86	-117.76	-101.48	-31.54	-16.36	-9.85
Capital Expenditures	-10.99	-10.84	-8.86	-14.68	-18.34	-9.12	-2.88	-1.86
Other Investing Activities	-	-	-	-	-0.33	-0.41	-	-
Investing Cash Flow	-10.99	-10.84	-8.86	-14.68	-18.67	-9.53	-2.88	-1.86
Share Issuance / Repurchase	0.03	163.97	246.03	80.21	115.96	156.92	127.69	32.22
Debt Issued / Paid	0	70	49.49	0	0	0	0	0
Other Financing Activities	-0.91	-10.36	-11.45	-5.8	-7.1	-	-	-
Financing Cash Flow	-0.88	223.61	284.06	74.42	108.86	156.92	127.69	32.22
Exchange Rate Effect	15.03	-28.38	-0.75	0.68	5.16	-5.83	0.56	-2.66
Net Cash Flow	-142.43	72.09	156.59	-57.35	-6.13	110.02	109.01	17.86
Free Cash Flow	-156.57	-123.15	-126.72	-132.44	-119.83	-40.66	-19.24	-11.7
Free Cash Flow Margin	-9221.02%	-1936.31%	-5438.54%	-7722.39%	-4120.53%	-2889.55%	-1136.21%	-965.68%
Free Cash Flow Per Share	-0.90	-1.30	-1.76	-2.57	-2.78	-1.29	-1.40	-1.18

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).